Residual DNA Sample Prep Kit for Vaccine

The development of vaccines is one of the most significant advances in medicine, protecting against a wide range of infectious diseases and thus saving millions of lives every year. However, the vaccine manufacturing process includes multiple steps, all of which must ensure the safety, efficacy and purity of the final product. One key aspect monitored by regulators and manufacturers is the residual DNA from host cells used in the manufacturing process. Residual DNA can pose a risk of carcinogenicity and infectiousness, so stringent measures are required to detect and quantify it. This background has led to the development of tools and kits specifically designed to prepare samples for the detection of residual DNA, such as the Vaccine Residual DNA Sample Preparation Kit.

Residual DNA originates from cell substrates used in the production of biopharmaceuticals, including vaccines - bacteria, yeast, mammalian or insect cells. Despite rigorous purification processes, trace amounts of host cell DNA may remain. The Vaccine Residual DNA Sample Preparation Kit is specifically designed to meet the stringent standards required to monitor and quantify trace amounts of host cell DNA. Given that the amount of residual DNA may be so small that it can be detected, the kit is optimized to extract and concentrate DNA even from highly purified samples.